AEterna Zentaris Inc. (AEZS)

[skitahoe]

AEZS could certainly go up or down dramatically based on the FDA decision, but I've got to believe that the worst thing we'll see from the FDA is delay, not denial. In that the only competition to this product dropped out of the market, I believe the FDA will want to see this product make the marketplace, but that doesn't mean they may not want some question answered before they approve.

I'd certainly look to buy more at the lows I'd expect if their are delays. I believe that AEZS represents far more than this drug, though they need the revenue this drug will bring. I believe the drug which might be a real sleeper is Perifosine which continues to be tested by its partner. It's sad, but a lack of funds caused AEZS and its partner KERX to drop all funding for trials of this drug after a trial failure. Positive news on the drug could bring it back to the forefront. Of course their are other strong possibilities, but nothing is expected from Perifosine, so positive news could really have a tremendous influence on this stock.

Gary